CS801986A2 - Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production - Google Patents

Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production

Info

Publication number: CS801986A2
Authority: CS; Czechoslovakia
Prior art keywords: opt; alkyl; substd; alkoxy; etherified
Prior art date: 1984-06-20

Application number

CS868019A

Other languages

English (en)

Other versions

CS268685B2 (en

Inventor

Leslie J Dr Browne

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-06-20

Filing date

1986-11-05

Publication date

1989-07-12

1984-06-20 Priority claimed from US06/622,421 external-priority patent/US4617307A/en

1986-11-05 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1986-11-05 Priority to CS868019A priority Critical patent/CS268685B2/cs

1989-07-12 Publication of CS801986A2 publication Critical patent/CS801986A2/cs

1990-04-11 Publication of CS268685B2 publication Critical patent/CS268685B2/cs

Links

JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title 1
MHOZZUICEDXVGD-UHFFFAOYSA-N pyrrolo[2,3-d]imidazole Chemical class C1=NC2=CC=NC2=N1 MHOZZUICEDXVGD-UHFFFAOYSA-N 0.000 title 1
-1 alkanoyl alkanoyloxy Chemical group 0.000 abstract 10
125000000217 alkyl group Chemical group 0.000 abstract 9
125000003545 alkoxy group Chemical group 0.000 abstract 6
229910052736 halogen Inorganic materials 0.000 abstract 6
150000002367 halogens Chemical class 0.000 abstract 6
125000001589 carboacyl group Chemical group 0.000 abstract 5
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 5
125000004423 acyloxy group Chemical group 0.000 abstract 4
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 4
125000004414 alkyl thio group Chemical group 0.000 abstract 3
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 3
125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 abstract 3
JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 2
229910006069 SO3H Inorganic materials 0.000 abstract 2
125000005078 alkoxycarbonylalkyl group Chemical group 0.000 abstract 2
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
125000004181 carboxyalkyl group Chemical group 0.000 abstract 2
125000004663 dialkyl amino group Chemical group 0.000 abstract 2
125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
125000003884 phenylalkyl group Chemical group 0.000 abstract 2
125000004660 phenylalkylthio group Chemical group 0.000 abstract 2
125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 2
102000014654 Aromatase Human genes 0.000 abstract 1
108010078554 Aromatase Proteins 0.000 abstract 1
229910006074 SO2NH2 Inorganic materials 0.000 abstract 1
125000005042 acyloxymethyl group Chemical group 0.000 abstract 1
125000004849 alkoxymethyl group Chemical group 0.000 abstract 1
125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 1
125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
125000005278 alkyl sulfonyloxy group Chemical group 0.000 abstract 1
125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 abstract 1
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
125000002619 bicyclic group Chemical group 0.000 abstract 1
125000005117 dialkylcarbamoyl group Chemical group 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 abstract 1
125000004970 halomethyl group Chemical group 0.000 abstract 1
CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
230000005764 inhibitory process Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

CS868019A 1984-06-20 1986-11-05 Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production CS268685B2 (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CS868019A CS268685B2 (en)	1984-06-20	1986-11-05	Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US06/622,421 US4617307A (en)	1984-06-20	1984-06-20	Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
CS854449A CS268672B2 (en)	1984-06-20	1985-06-18	Method of substituted imidazo-(1,5-a)pyridine derivatives production
CS868019A CS268685B2 (en)	1984-06-20	1986-11-05	Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production

Publications (2)

Publication Number	Publication Date
CS801986A2 true CS801986A2 (en)	1989-07-12
CS268685B2 CS268685B2 (en)	1990-04-11

Family

ID=25745999

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
CS868019A CS268685B2 (en)	1984-06-20	1986-11-05	Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
CS868018A CS268684B2 (en)	1984-06-20	1986-11-05	Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
CS868021A CS268687B2 (en)	1984-06-20	1986-11-05	Method of substituted imidazopyridine derivatives production

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
CS868018A CS268684B2 (en)	1984-06-20	1986-11-05	Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
CS868021A CS268687B2 (en)	1984-06-20	1986-11-05	Method of substituted imidazopyridine derivatives production

Country Status (1)

Country	Link
CS (3)	CS268685B2 (cs)

1986
- 1986-11-05 CS CS868019A patent/CS268685B2/cs not_active IP Right Cessation
- 1986-11-05 CS CS868018A patent/CS268684B2/cs not_active IP Right Cessation
- 1986-11-05 CS CS868021A patent/CS268687B2/cs not_active IP Right Cessation

Also Published As

Publication number	Publication date
CS268687B2 (en)	1990-04-11
CS802186A2 (en)	1989-07-12
CS801886A2 (en)	1989-07-12
CS268684B2 (en)	1990-04-11
CS268685B2 (en)	1990-04-11

Similar Documents

Publication	Publication Date	Title
SE8802815L (sv)	1989-02-05	Epipodofyllotoxin-glukosid-4'-fosfat-derivat
DK0585242T3 (da)	1999-12-06	Sårheling
PT646012E (pt)	2003-03-31	Cura de feridas e tratamento de perturbacoes fibroticas por tgfbeta-3
EP0213776A3 (en)	1989-05-03	Use of a cartilage-inducing factor (cif) for the manufacture of a medicament for treating inflammation
TR200201052T2 (tr)	2003-01-21	Yeni hücre farklılaştırıcı ajanlar sınıfı ve hıstone deacetylase inhibitörleri, ve burada kullanım yöntemleri
LU90128I2 (fr)	1997-10-06	Létrozole et ses sels et dérivés pharmaceutiquement acceptables (Femara)
NZ331741A (en)	2000-08-25	use of a quinazolin-4-one derivative having an (S)-configuration to treat dyskinesia associated with dopamine agonist therapy
Cassin et al.	1986	The effects of bumetanide and furosemide on lung liquid secretion in fetal sheep
IS1549B (is)	1994-06-08	1,4 - Dihydropyridines, og aðferð við framleiðsluþess svo og notkun þess í lækningaskyni
NZ333063A (en)	2000-12-22	Dibenzofuran sulfonamide derivatives as matrix metalloproteinase inhibitors
CS801886A2 (en)	1989-07-12	Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
CS802086A2 (en)	1989-07-12	Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
DE69807710D1 (de)	2002-10-10	Verwendung von Latenz Assoziierten Peptiden in der Herstellung eines Medikaments zur Verbesserung der Wundheilung.
NO880731L (no)	1988-08-22	Fremgangsmaate for fremstilling av farmasoeytisk aktive naftalenderivater.
DE60017147D1 (de)	2005-02-03	Verwendung von gabab-rezeptor agonisten und deren pharmazeutisch akzeptierbaren derivate bei der therapie zur erhaltung von nikotinabstinenz bei nikotinabhängigen patienten
EA200100214A1 (ru)	2001-08-27	Применение производных камптотецина с пониженной гастроинтестинальной токсичностью
NO953204L (no)	1996-02-19	Substituerte kinolinderivater, fremgangsmåte for deres fremstilling og deres anvendelse
DK0533210T3 (da)	1997-11-03	Protein C-holdige farmaceutiske præparater som midler mod inflammation.
Tomono et al.	1995	Synergistic potentiating effects of choline phosphate and ethanolamine on insulin-induced DNA synthesis in NIH 3T3 fibroblasts
AU3818989A (en)	1990-01-25	The use of substituted 3,4-dihydro-2h-benzopyrans as remedies for constructive functional disorders of the lungs and/or disorders of the efferent urinary passages
FR2350101A1 (fr)	1977-12-02	Nouvelles guanidines cyclisees
Klos et al.	1985	Prilocaine-induced methemoglobinemia in a child with Shwachman syndrome
FR2307536A1 (fr)	1976-11-12	Derives d'acide 5-sulfamoyl-anthranilique a substituants basiques et leur procede de preparation
EP0327052A3 (en)	1990-12-12	Use of quinoline derivatives for making a medicament effective in the prevention and treatment of ulcers
FR2148363A1 (en)	1973-03-23	Dihydrobenzopyran derivs - as cardiac and respiratory analeptic agents and hypo tensive agents

Legal Events

Date	Code	Title	Description
2000-08-16	MK4A	Patent expired	Effective date: 20000618